NM_000157.4(GBA):c.1060G>C (p.Asp354His) AND not specified

Clinical significance:Uncertain significance (Last evaluated: Oct 15, 2018)

Review status:1 star out of maximum of 4 stars

criteria provided, single submitter

Based on:
1 submission [Details]
Record status:

Allele description [Variation Report for NM_000157.4(GBA):c.1060G>C (p.Asp354His)]

NM_000157.4(GBA):c.1060G>C (p.Asp354His)

LOC106627981:GBA recombination region [Gene]
GBA:glucosylceramidase beta [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Genomic location:
Preferred name:
NM_000157.4(GBA):c.1060G>C (p.Asp354His)
  • NC_000001.11:g.155236409C>G
  • NG_009783.1:g.13289G>C
  • NG_042867.1:g.2871C>G
  • NM_000157.4:c.1060G>CMANE SELECT
  • NM_001005741.2(GBA):c.1060G>C
  • NM_001005741.3:c.1060G>C
  • NM_001005742.3:c.1060G>C
  • NM_001171811.2:c.799G>C
  • NM_001171812.2:c.913G>C
  • NP_000148.2:p.Asp354His
  • NP_001005741.1:p.Asp354His
  • NP_001005741.1:p.Asp354His
  • NP_001005742.1:p.Asp354His
  • NP_001165282.1:p.Asp267His
  • NP_001165283.1:p.Asp305His
  • NC_000001.10:g.155206200C>G
  • NM_001005741.2(GBA):c.1060G>C
  • NM_001005741.2:c.1060G>C
  • P04062:p.Asp354His
Protein change:
UniProtKB: P04062#VAR_003292; dbSNP: rs398123526
NCBI 1000 Genomes Browser:
Molecular consequence:
  • NM_000157.4:c.1060G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001005741.3:c.1060G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001005742.3:c.1060G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001171811.2:c.799G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001171812.2:c.913G>C - missense variant - [Sequence Ontology: SO:0001583]


MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
SCV000919417Women's Health and Genetics/Laboratory Corporation of America, LabCorpcriteria provided, single submitter
Uncertain significance
(Oct 15, 2018)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing



Three unrelated Gaucher's disease patients with three novel point mutations in the glucocerebrosidase gene (P266R, D315H and A318D).

Walley AJ, Ellis I, Harris A.

Br J Haematol. 1995 Oct;91(2):330-2.

PubMed [citation]

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000919417.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)


Variant summary: GBA c.1060G>C (p.Asp354His) results in a non-conservative amino acid change located in the Glycosyl hydrolase family 30, TIM-barrel domain of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 121322 control chromosomes. c.1060G>C has been reported in the literature in an individual affected with Gaucher Disease (Walley_1995). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as VUS - possibly pathogenic.

OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 18, 2021

Support Center